SuperTruth and imaware selected by Harbinger Health for its cancer detection program

SuperTruth Inc. and imaware, its diagnostics company, were selected by Harbinger Health, a Flagship Pioneering company, through a competitive RFP to provide the clinical trial support platform, data warehouse, and data rationalization processes behind Harbinger's cancer detection program.

The RFP drew a field of established vendors. The requirement was a partner that could run the clinical trial support platform and own the data layer beneath it, not one or the other: trial data collected cleanly, warehoused once, and reconciled before anyone reasons over it. SuperTruth and imaware were selected for both layers, and every condition of the award was met in full.

“Cancer detection can't wait on data that gets warehoused twice and reconciled by hand. Harbinger needed a partner that treats the data layer as seriously as the science, and that's exactly what we built SuperTruth to be.”

Jason Alan Snyder, co-founder, SuperTruth

Under the selection, imaware provides the clinical trial support platform and lab operations, and SuperTruth provides the data warehouse and the rationalization processes that make disparate trial data answer as one record, with every element carrying its source, its consent, and its age.